News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023
News Conference News CRT 2023 ‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes Yael L. Maxwell February 27, 2023
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News TCT 2021 EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI Michael O'Riordan October 15, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News ESC 2018 Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated Todd Neale September 04, 2018
News Conference News ESC 2018 SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions Shelley Wood August 31, 2018
News Conference News ESC 2018 Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND Michael O'Riordan August 26, 2018
News Conference News AHA 2017 Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins Caitlin E. Cox November 14, 2017
News Conference News ESC 2017 Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab Michael O'Riordan August 28, 2017
News Conference News AHA 2015 Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower Yael L. Maxwell November 08, 2015